Used in organic synthesis as a key intermediate for pharmaceuticals, particularly in the preparation of fluorinated biaryl compounds via Suzuki-Miyaura cross-coupling reactions. Its boronic acid group enables efficient carbon-carbon bond formation, making it valuable in drug development for oncology and central nervous system disorders. The presence of both a fluorine atom and a carbamoyl group allows for enhanced binding selectivity and metabolic stability in target molecules. Commonly employed in research settings for constructing complex aromatic frameworks in medicinal chemistry.